RESUMO
Background: Although emerging evidence emphasizes the associations between both insulin resistance and hyperuricemia with coronary artery disease (CAD) risk, no definite relationship has yet been established. In this respect, time-efficient and affordable methods to estimate insulin resistance (IR) status, and to predict risk of hyperuricemia, are needed. Thus, the goal of this investigation was to examine the associations between IR, as assessed by novel surrogate markers [triglyceride-glucose (TyG) and TyG-body mass index (TyG-BMI)], and risk of hyperuricemia in patients with and without diagnosed CAD. Methods: This cross-sectional study used data from the medical records of 1,170 patients who were referred to the cardiology outpatient clinic. Medical records, anthropometrics, and serum analytes were determined at the initial visit. Hyperuricemia was defined as serum uric acid ≥ 5.6 mg/dL. IR was estimated through surrogate markers (TyG and TyG-BMI). Multiple regression analysis was performed to assess the relationship between these indices and odds of hyperuricemia among patients with and without CAD. Results: Overall, 814 angiographically-confirmed CAD cases (mean age (SD) = 52 (8)yrs) were compared with 356 patients without CAD (mean age (SD) = 48 (8)yr). There were positive associations between TyG and TyG-BMI indices and odds of hyperuricemia in CAD patients after controlling for confounders (adjusted odds ratio (aOR) = 1.60; 95%CI: 1.02-2.51; p-value = 0.036; and aOR = 1.83; 95%CI: 1.24-2.70; p-value = 0.002, third tertiles for TYG and TYG-BMI, respectively). Conclusion: The present findings suggest that higher levels of the IR surrogate markers, TyG and TyG-BMI, are associated with higher odds of hyperuricemia in patients with CAD. However, given the cross-sectional design of this study, the sensitivity and specificity of these novel markers could not be determined for confirming the diagnosis of IR and hyperuricemia, further studies are needed to determine such outcomes and to confirm the current findings.
RESUMO
Introduction: During the recent years, several studies have investigated that hyperuricemia is associated with greater incidence of contrast induced nephropathy (CIN). Most of them are in acute conditions like primary percutaneous coronary interventions. This study aimed to assess the relationship between high serum uric acid and incidence of acute kidney injury in patients undergoing elective angiography and angioplasty. Methods: This prospective study was conducted on 211 patients who were admitted to hospital for elective coronary angiography or angioplasty. The researchers measured serum creatinine and uric acid on admission and repeated creatinine measurement in 48 hours and seven days after the procedure. According to serum uric acid, the patients were divided into two groups; group 1 with normal uric acid and group 2 with hyperuricemia which was defined as uric acid more than 6 mg/dL in women and 7 mg/dL in men. CIN is defined as an increased creatinine level of more than 0.5 mg/dL or 25% from the baseline in 48 hours after the intervention. Results: In total, 211 patients with mean age of 60.58 years were enrolled in the study. Of these, 87 (41.2%) patients were in the high uric acid group and 124 (58.8%) were in the normal uric acid group. CIN was occurred in 16 patients (7.5%). Seven out of 16 (8.04%) were in the high uric acid and nine (7.2%) were in the normal uric acid group. There were no significant differences between the two groups (P =0.831). Conclusion: The frequency of CIN development was not different in the patients with hyperuricemia.
RESUMO
INTRODUCTION: Electrocardiography parameters can predict cardiac events in ischemia. QT-interval parameters are potentially proposed as available non-invasive markers for assessing the ventricular homogeneity and electrical instability. Prolonged QT-interval (QTI) and QT dispersion (QTd) are predictors of poor prognosis and fatal arrhythmias. The improvement of cardiac perfusion may decrease QTI via percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery. The aim of this study was to compare the effects of PCI and CABG on QT parameters in chronic ischemia. METHODS: A total of 141 consecutive patients with coronary artery disease (70 who underwent PCI and 71 who underwent CABG) were entered into the study. Standard 12-lead electrocardiograms were recorded immediately before the procedure, immediately post procedure, 24 hours post procedure, and 7 days post procedure; corrected QTI (QTc) and corrected QTd (QTcd) and their changes were assessed and compared across the two therapeutic groups. RESULTS: QTc and QTcd reduced significantly after 7 days of revascularization. After PCI, QTc reduced from 444.7 ± 46.9 msec to 427.4 ± 40.6 msec and QTcd reduced from 47.1 ± 23.3 msec to 38.1 ± 1.1 msec. QTc increased immediately after CABG from 443.2 ± 36.6 msec to 461.9 ± 38.1 msec, but reduced within 7 days of the procedure to 430.2 ± 28.2 msec. QTcd reduced from 49.6 ± 23.2 msec to 30.9 ± 3.9 msec. The trend of QTcd reduction were similar in the two therapeutic groups but the trend of QTc alteration was different in that QTc increased upwardly and then decreased after CABG. CONCLUSION: Revascularization in chronic ischemia can improve QTI parameters following both PCI and CABG.
